Oral bioadhesive drug delivery systems

被引:97
作者
Bruschi, ML
de Freitas, O
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, BR-14040903 Ribeirao Preto, SP, Brazil
[2] Univ Estadual Maringa, Dept Farm & Farmacol, Maringa, Parana, Brazil
关键词
bioadhesion; oral mucosa; oral cavity; buccal; drug delivery systems;
D O I
10.1081/DDC-200052073
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The oral mucosal cavity is a feasible, safe, and very attractive site for drug delivery with good acceptance by users. The mucosa is relatively permeable and robust, shows short recovery times after stress or damage, is tolerant to potential allergens, and has a rich blood supply. Moreover, oral mucosal drug delivery bypasses the first-pass effect and avoids presystemic elimination in the gastrointestinal tract. Bioadhesive systems provide intimate contact between a dosage form and the absorbing tissue, which may result in high concentration in a local area and hence high drug flux through the absorbing tissue. The efficacy of oral bioadhesive drug delivery systems is affected by the biological environment and the properties of the polymer and the drug. In the present paper, we review systematically some relevant citations regarding the environment, strategies for oral drug delivery and evaluation, and utilization of the main polymers.
引用
收藏
页码:293 / 310
页数:18
相关论文
共 101 条
[1]   Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine [J].
Agarwal, V ;
Mishra, B .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (06) :701-709
[2]   Mucoadhesive drug delivery systems [J].
Shaikh, Rahamatullah ;
Singh, Thakur Raghu Raj ;
Garland, Martin James ;
Woolfson, A. David ;
Donnelly, Ryan F. .
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2011, 3 (01) :89-100
[3]   Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation [J].
Ali, J ;
Khar, R ;
Ahuja, A ;
Kalra, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 238 (1-2) :93-103
[4]   Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets [J].
Alur, HH ;
Beal, JD ;
Pather, SI ;
Mitra, AK ;
Johnston, TP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (12) :1313-1319
[5]   Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets [J].
Alur, HH ;
Pather, SI ;
Mitra, AK ;
Johnston, TP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 188 (01) :1-10
[6]   Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly(acrylic acid) copolymers and starch/poly(acrylic acid) mixtures [J].
Ameye, D ;
Voorspoels, J ;
Foreman, P ;
Tsai, J ;
Richardson, P ;
Geresh, S ;
Remon, JP .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :173-182
[7]   EVALUATION OF LAMINATED MUCO-ADHESIVE PATCHES FOR BUCCAL DRUG DELIVERY [J].
ANDERS, R ;
MERKLE, HP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 49 (03) :231-240
[8]   Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies [J].
Artusi, M ;
Santi, P ;
Colombo, P ;
Junginger, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 250 (01) :203-213
[9]   SITE DEPENDENCE OF ABSORPTION-PROMOTING ACTIONS OF LAURETH-9, NA SALICYLATE, NA2EDTA, AND APROTININ ON RECTAL, NASAL, AND BUCCAL INSULIN DELIVERY [J].
AUNGST, BJ ;
ROGERS, NJ .
PHARMACEUTICAL RESEARCH, 1988, 5 (05) :305-308
[10]  
Beyssac E, 1998, BIOPHARM DRUG DISPOS, V19, P401, DOI 10.1002/(SICI)1099-081X(199809)19:6<401::AID-BDD116>3.3.CO